CH EPL (R5)
0.1.0 - ci-build

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Datasource Authorised Medicinal Product
... 4 Dataexport FOPH Spezialitätenliste
... 5 Use Cases
... 6 Cuprior
... 7 Entocort
... 8 Estalis
... 9 Keytruda
... 10 Paxlovid
... 11 Triogen
... 12 Profiles
... 13 Extensions
... 14 Terminology
... 15 Changelog
... 16 Artifacts Summary
.... 16.1 CH EPL Organization
.... 16.2 CH IDMP AdministrableProductDefinition
.... 16.3 CH IDMP ClinicalUseDefinition Indication
.... 16.4 CH IDMP DocumentReference
.... 16.5 CH IDMP ManufacturedItemDefinition
.... 16.6 IDMP Bundle
.... 16.7 IDMP Ingredient
.... 16.8 IDMP MedicinalProductDefinition
.... 16.9 IDMP PackagedProductDefinition
.... 16.10 IDMP RegulatedAuthorization
.... 16.11 FOPH Dossier Number
.... 16.12 GLN Identifier
.... 16.13 LOC Identifier
.... 16.14 CH - EPL Full Limitation Text
.... 16.15 CH - EPL Product Price
.... 16.16 CH - EPL Regulated Authorization Limitation
.... 16.17 CH - EPL Reimbursement SL
.... 16.18 CH - SMC Authorized Dose Form
.... 16.19 CH - Authorisation Type
.... 16.20 CH - Medicinal Product Name Type
.... 16.21 CH - Product Characteristics Type
.... 16.22 CH EPL - Gamme
.... 16.23 CH EPL - Limitation Status
.... 16.24 CH EPL - Listing Status
.... 16.25 CH EPL - Other Characteristics Packaged Item
.... 16.26 CH EPL - Price Type
.... 16.27 CH EPL - Product Type
.... 16.28 CH EPL - Reimbursement Status
.... 16.29 CH EPL - Type of Price Change
.... 16.30 CH SMC - Attached Document Type
.... 16.31 CH SMC - Authorisation Status
.... 16.32 CH SMC - Authorised Pharmaceutical Dose Form
.... 16.33 CH SMC - Ingredient Role
.... 16.34 CH SMC - Legal Status of Supply
.... 16.35 CH SMC - Marketing Status
.... 16.36 CH SMC - Pediatric Use Indicator
.... 16.37 CH SMC - Special Precautions for Storage
.... 16.38 CH SMC - Substance
.... 16.39 CH SMC - TherapeuticProductcode
.... 16.40 CH SMC- Additional Monitoring Indicator
.... 16.41 EDQM - Combination Packaging
.... 16.42 EDQM - Combined Pharmaceutical Dose Form
.... 16.43 EDQM - Combined Term
.... 16.44 EDQM - Packaging
.... 16.45 EDQM - Pharmaceutical Dose Form
.... 16.46 EDQM - Route Of Administration
.... 16.47 EDQM - Unit of Presentation
.... 16.48 EMA - Domain
.... 16.49 EMA - Intended Effect
.... 16.50 EMA - Shelf Life Type
.... 16.51 CH - Authorisation Type
.... 16.52 CH - Medicinal Product Name Type
.... 16.53 CH - Product Characteristics Type
.... 16.54 CH EPL - Gamme
.... 16.55 CH EPL - Limitation Status
.... 16.56 CH EPL - Listing Status
.... 16.57 CH EPL - Other Characteristics Packaged Item
.... 16.58 CH EPL - Price Type
.... 16.59 CH EPL - Product Type
.... 16.60 CH EPL - Reimbursement Status
.... 16.61 CH EPL - Type of Price Change
.... 16.62 CH SMC - Additional Monitoring Indicator
.... 16.63 CH SMC - Attached Document Type
.... 16.64 CH SMC - Authorisation Status
.... 16.65 CH SMC - Ingredient Role
.... 16.66 CH SMC - Legal Status of Supply
.... 16.67 CH SMC - Marketing Status
.... 16.68 CH SMC - Pediatric Use Indicator
.... 16.69 CH SMC - Special Precautions for Storage
.... 16.70 CH SMC - Substance
.... 16.71 CH SMC - TherapeuticProductcode
.... 16.72 EDQM - Standard Terms
.... 16.73 EMA - RMS
.... 16.74 5204201
.... 16.75 52042011
.... 16.76 5470402
.... 16.77 54704089
.... 16.78 66231001
.... 16.79 6623101
.... 16.80 67431001
.... 16.81 6743101
.... 16.82 67719001
.... 16.83 6771901
.... 16.84 68793001
.... 16.85 6879301
.... 16.86 CH-52042011
.... 16.87 CH-54704089
.... 16.88 CH-66231001
.... 16.89 CH-67431001
.... 16.90 CH-68291001
.... 16.91 CH-68793001
.... 16.92 CUPRIOR Filmtabl 150 mg 72 Stk
.... 16.93 CUPRIOR Filmtabl 150 mg 72 Stk (Bundle)
.... 16.94 Cuprior, Filmtabletten Fachinformation
.... 16.95 Cuprior, Filmtabletten Patienteninformation
.... 16.96 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 16.97 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 16.98 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 16.99 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 16.100 ESTALIS Matrixpfl 50/250 24 Stk
.... 16.101 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 16.102 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 16.103 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 16.104 Indication 10009900
.... 16.105 Indication 10019927
.... 16.106 Indication 10021782
.... 16.107 Indication 10027400
.... 16.108 Indication 10028881
.... 16.109 Indication 10030247
.... 16.110 Indication 10031285
.... 16.111 Indication 10043971
.... 16.112 Indication 10061091
.... 16.113 Indication 10075566
.... 16.114 Indication 10084529
.... 16.115 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 16.116 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 16.117 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 16.118 Limitation 254837009
.... 16.119 Limitation 79886009
.... 16.120 Limitation 840539006
.... 16.121 MI Budesonidum-2.3mg-Tablet
.... 16.122 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 16.123 MI Nirmatrelvir-150mg-Tablet
.... 16.124 MI Pembrolizumab-100mg-Vial
.... 16.125 MI Ritonavirum-100mg-Tablet
.... 16.126 MI Solvent
.... 16.127 MI Trientinum-150mg-Tablet
.... 16.128 MI Trientinum-250mg-Capsule
.... 16.129 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 16.130 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 16.131 Paxlovid, Filmtabletten Patienteninformation
.... 16.132 PhP Budesonidum-Suspension
.... 16.133 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 16.134 PhP Pembrolizumab-100mg-Vial
.... 16.135 PhP Trientinum-150mg-Tablet
.... 16.136 PhP Trientinum-150mg-Tablet
.... 16.137 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 16.138 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 16.139 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 16.140 Reimbursement SL 17418
.... 16.141 Reimbursement SL 17973
.... 16.142 Reimbursement SL 20416
.... 16.143 Reimbursement SL 21070
.... 16.144 Reimbursement SL 21208
.... 16.145 Reimbursement SL 21529
.... 16.146 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 16.147 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 16.148 Triogen, Kapseln Fachinformation
.... 16.149 Triogen, Kapseln Patienteninformation